Royalty Pharma: Pay

Royalty Pharma paid its 5 named executives $6.2M in total in FY2025 (Dec). CEO Pablo Legorreta was paid $937.5K of that.

Pay$100 in the stock at the end of FY24 → $151
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Christopher HiteExecutive Vice President & Vice Chairman
FY2025 (Dec)
FY2024 (Dec)Not disclosed
FY2023 (Dec)Not disclosed
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
George LloydSenior Advisor; former Executive Vice President, Chief Legal Officer & Investments
FY2025 (Dec)
FY2024 (Dec)Not disclosed
FY2023 (Dec)Not disclosed
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Marshall Urist, M.D., Ph.D.Executive Vice President, Research & Investments
FY2025 (Dec)
FY2024 (Dec)Not disclosed
FY2023 (Dec)Not disclosed
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Terrance CoyneExecutive Vice President & Chief Financial Officer
FY2025 (Dec)
FY2024 (Dec)Not disclosed
FY2023 (Dec)Not disclosed
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Pablo LegorretaChief Executive Officer
FY2025 (Dec)
1 year

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 8 peers with pay on file was $29.8M. The CEO of Royalty Pharma was paid $937.5K, 97% below the median.

  1. 1Ares Management
  2. 2Johnson & Johnson
  3. 3AbbVie
  4. 4Incyte
  5. 5Pfizer
  6. 6Amgen
  7. 7Bristol Myers Squibb
  8. 8Merck & Co.
  9. 9Royalty Pharma
  10. 10ApolloNot disclosed
  11. 11BioMarinNot disclosed
  12. 12BiogenNot disclosed
  13. 13BlackstoneNot disclosed
  14. 14Blue OwlNot disclosed
  15. 15CarlyleNot disclosed
  16. 16Eli LillyNot disclosed
  17. 17GileadNot disclosed
  18. 18KKR & Co.Not disclosed
  19. 19RegeneronNot disclosed
  20. 20TPGNot disclosed
  21. 21Vertex PharmaceuticalsNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.